Inhibition of miR-22-3p reduces kidney disease associated with systemic lupus erythematosus
D. L. Michell, A. Faust, J. L. Moore, B. D. Appleton, M. Ormseth, M. Ramirez-Solano, Q. Sheng, J. F. Solus, C. M. Stein, K. C. Vickers, A. S. Major
This study shows that inhibiting miR-22-3p reduces lymphocyte accumulation and kidney disease in a mouse model of systemic lupus erythematosus.
bioRxiv · Jan 7, 2019 · PreprintImmunology